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http:WHAT THIS PAPER ADDS
The use of a novel medical imaging technology called Vascular Optical Tomographic Imaging (VOTI) is presented
to assess peripheral arterial disease (PAD) in the foot. VOTI can non-invasively image blood volume oxy- and
deoxy-hemoglobin concentrations over time, without any contrast, and is independent of arterial compress-
ibility. This makes it ideal for diagnosing and monitoring diabetic patients, who are prone to arterial calciﬁcations
and are sensitive to the nephrotoxic contrast agents. This 40 patient pilot study is the ﬁrst attempt at quan-
titatively assessing VOTI’s performance in diagnosing PAD.Objective: Vascular optical tomographic imaging (VOTI) is a novel imaging modality that is capable of detecting
hemoglobin concentrations in tissue. VOTI is non-invasive, non-ionizing and does not require contrast injection.
This technology was applied to the diagnosis of peripheral arterial disease (PAD) within lower extremities of
diabetic patients with calciﬁed arteries. This could be of substantial beneﬁt as these patients suffer from
comorbidities such as arterial incompressibility, which complicates diagnosis and monitoring.
Methods: Forty individuals (10 non-diabetic patients with PAD, 10 diabetic patients with PAD, and 20 healthy
volunteers) were enrolled in a diagnostic pilot study using the VOTI system. The patients were imaged during a
thigh pressure cuff occlusion.
Results: The VOTI system was capable of quantifying the blood volume changes within the foot during the thigh
cuff occlusion and outputting diagnostic parameters, such as change in hemoglobin concentration, enabling the
assessment of foot perfusion. This study resulted in a statistically signiﬁcant difference between the healthy
cohort and both the non-diabetic and the diabetic PAD cohorts (p ¼ .006, p ¼ .006). Receiver operating
characteristic (ROC) curve analysis showed that PAD diagnosis could be made with over 80% sensitivity or
speciﬁcity depending on the characteristic cutoff point. In addition, VOTI was capable of providing the locations
of under-perfused regions within the foot and evaluating the severity of arterial disease, even within diabetic
patients with calciﬁed arteries, who are traditionally difﬁcult to diagnose.
Conclusion: VOTI can effectively diagnose PAD independently of arterial compressibility, making it very useful for
assessing vascular disease in diabetic patients.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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PAD affects 8e12 million people in the United States.When
linked with diabetes, PAD results in over 71,000 amputa-
tions annually. Currently 85% of lower leg amputations
occur within diabetic patients. Lower extremity angioplasty
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//dx.doi.org/10.1016/j.ejvs.2014.10.010limb threatening ischemia occurs. Accurate and timely
diagnosis of PAD is crucial in preventing further health
consequences.1e6
In patients with compressible vessels, detection of PAD is
accomplished by calculating the ankle-brachial index (ABI).
However, in patients with diabetes and renal insufﬁciency,
ABI measurements may be falsely elevated because of
arterial calciﬁcation. In such cases, pulse-volume recording
(PVR) waveforms offer some help, but are unreliable in
cases of low ﬂow states and edema.1e9 Toe-brachial index
(TBI) is sometimes considered in patients with calciﬁed
vessels, but a recent review of the TBI concluded that the
diagnostic criteria remain ambiguous.8
Figure 1. The VOTI system with its sandal shaped measuring probe
provides cross sectional images of hemoglobin concentrations in
the foot.
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ultrasound (DUS) and computed tomography angiography
(CTA). However, it can be difﬁcult to identify lesions below
the knee with DUS because of the relatively small size of the
arteries, which makes this method increasingly operator
dependent as it is applied more distally. If this examination
is inconclusive (DUS fails to visualize up to 15% of arterial
segments in the calf), CTA is employed to provide further
details on the location and extent of the occlusion in the
leg.9 However, CTA requires nephrotoxic contrast agents,
which are not suitable for diabetic and renal disease pa-
tients.7e9
Furthermore, all these methods are indirect measure-
ments of distal perfusion; yet it is the lack of distal perfusion
in the foot that leads to ischemic ulcers and amputations.
Therefore, a direct measure of foot perfusion is highly
desirable. Vascular optical tomographic imaging (VOTI) has
the potential to provide this measure and aid in PAD
assessment.7e9
The VOTI system in the present study uses red and near
infrared (NIR) light (650 < l < 900 nm) similar to a pulse
oximeter. The light is used to illuminate the foot at various
points. The transmitted light is used to create cross
sectional images of hemoglobin concentration in the foot.
These hemoglobin spatial maps can be derived, non-
invasively, without contrast agents or ionizing radiation.
NIR light has no adverse health effects allowing for frequent
measurements in patient monitoring. VOTI penetrates
deeper than laser Doppler providing better information
about perfusion at the cost of lower spatial resolutions.
Furthermore, this technology is independent of arterial
calciﬁcation making it ideal for diagnosing diabetic PAD
patients.10e23
The present group previously published results of a case
study of three individuals using the VOTI system.19 A
healthy volunteer, a PAD patient, and a patient with PAD
and diabetes were imaged during a thigh cuff occlusion. The
individuals reacted differently to the cuff occlusion with
respect to the amount and rate at which the blood pooled
in the foot. VOTI effectively diagnosed PAD within a diabetic
patient with calciﬁed arteries, which is problematic with
current diagnostic methods. In this paper, results from a
pilot study of 40 individuals (20 healthy volunteers, 10 non-
diabetic PAD patients, and 10 patients with PAD and dia-
betes) are presented to quantify VOTI’s sensitivity and
speciﬁcity at detecting PAD, its ability to assess the severity
of the disease and localize the perfusion response in the
foot.
METHODS
Study population
Forty individuals were recruited for this IRB approved
diagnostic pilot study in the Division of Vascular Surgery at
New York Presbyterian Hospital - Columbia University. The
patients were placed into three cohorts: healthy volunteers
(N ¼ 20), PAD patients without diabetes (N ¼ 10), and PAD
patients with diabetes (N ¼ 10). The physicians assigned thepatients to one of the three cohorts based on a combina-
tion of the patients’ ABI readings, segmental ultrasound
waveforms, physical symptoms, and medical history.
The patients recruited were 75% male and 25% female,
with a mean age of 67.5  11.5 years. Of the patients
recruited, 10% were current smokers and 20% had been
smokers in the past. The ethnic make up was 55% Hispanic,
25% Non-Hispanic White, 10% African American, and 10%
Asian American. Of the healthy volunteers, none were
smokers or had smoked habitually in the past. The healthy
volunteers were 80% male and 20% female, with a mean
age of 35.6  10.0 years. The ethnic make up was 5%
Hispanic, 60% Non-Hispanic White, 5% African American,
and 30% Asian American.
This pilot study attempts to differentiate between
healthy and affected vasculature. As aging reduces vaso-
reactivity, it is difﬁcult to match the ages of the healthy and
affected cohorts in a pilot study of this size. Furthermore, a
large part of the data analysis compares the patients’ VOTI
readings with their respective ABI/PVR readings, in which
age is not a factor. This analysis was only completed on the
affected cohorts to see how the VOTI readings correlate
with current techniques.Vascular Optical Tomography Imaging System
The individuals were imaged using a VOTI system.20 The
system uses two NIR wavelengths (l1 ¼ 760 and
l2 ¼ 830 nm) to illuminate the tissue with a frame rate of
approximately 6 Hz. Fast hardware instrumentation enables
the measuring of blood volume dynamics within the cross
section of tissue, which allows us to image hemodynamics
during a pressure cuff application. A total of 34 ﬁbers
encompassed the foot, forming a coronal cross section at
the mid-metatarsal level. These ﬁbers shine light through
the foot and capture the back-reﬂected and transmitted
light (Fig. 1). The imaging takesw10 minutes to set up and
w5 minutes to acquire the images.
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age reconstruction algorithm21 to create spatial maps of
hemoglobin within the cross section of the foot. If perfusion
is low there is less hemoglobin in the foot. Hemoglobin is
the major absorber of light in tissue, the higher its con-
centration the weaker the detected intensities. The mid-
metatarsal level was chosen to assess the vessels (i.e.
dorsalis pedis, plantar arteries) that supply the forefoot,
which is the most common location for diabetic foot ulcers.
Imaging protocol
A ﬁve stage dynamics imaging protocol was employed to
image the individuals, who were seated upright in a chair
and asked to place their foot inside the measuring probe
(Fig. 1). To illicit a controlled vascular response a pressure
cuff was applied to the thigh. The protocol consisted of
(1) rest phase, (2) 60 mmHg thigh cuff occlusion phase,
(3) release and recovery phase, (4) 120 mmHg thigh cuff
occlusion phase, and (5) release and recovery phase.
Initially, the patient was imaged at rest for 1 minute. Then in
the second phase, a pressure cuff was inﬂated to 60 mmHg
to induce venous occlusion for 1 minute. The thigh cuff
prevented the blood from leaving the leg through the veins,
while arteries continued to supply blood to the foot. This
pressure caused the blood to pool in the leg, which
absorbed the light as it propagated through the foot,
decreasing the intensity of the detected signal. In the third
phase, the pressure was released allowing for 1 minute of
recovery time. In the fourth phase, the thigh cuff was
reapplied at 120 mmHg for 1 minute, inducing a greater
venous occlusion. Finally, the cuff was released and the
patient was imaged for 1 minute. This protocol was selected
because it focuses on arterial ﬂow, while avoiding the
arterial compression required by blood pressure based
measurements.
Feature extraction
To derive quantitative parameters for diagnosis, regions of
interest (ROI) were extracted from within the VOTI im-
ages.19 Certain pixel intensities correlated with the appli-
cation of the pressure cuff around the thigh. These
correlating pixels clustered together suggesting that they
may correspond with vascular anatomy. The changes in the
hemoglobin concentrations were extracted over time
directly from these ROI. The peak of these hemoglobin time
traces during the 60 mmHg pressure cuff occlusion (amount
of blood pooling before cuff release) was used to diagnose
PAD.
Statistical methods
The features extracted from the images were analyzed
relative to a baseline (percent changes). The data were in
the form of mean and standard deviations unless otherwise
stated. The individuals were stratiﬁed into healthy and
affected vasculature cohorts. The affected vasculature co-
horts were further stratiﬁed into non-diabetic and diabetic
PAD patients to determine the effect of diabeticcomorbidities. To quantify VOTI’s diagnostic ability, com-
parisons between groups were made using a one-way
analysis of variance (ANOVA). However, ANOVA only tests
the global hypothesis that all the samples were drawn from
a single population. To identify the cohorts with statistically
signiﬁcant differences, a multiple comparison procedure
called the Holm t-test was applied. For a 95% conﬁdence
interval, and three cohorts a1 ¼ 0.0167, a2 ¼ 0.025,
a3 ¼ 0.05 were obtained as signiﬁcance cutoffs. In addition,
receiver operating characteristic (ROC) curves were created
to calculate the sensitivity and speciﬁcity of the VOTI
system.
To identify VOTI’s ability to assess the severity of PAD, the
data were analyzed using boxplots. The boxplots provide a
graphical representation of the minimum and maximum
values and the quartiles of the data. This allows visualization
of the range, shape, and skewness of the data. VOTI’s
diagnostic features were compared with patients’ ABI
values and PVR readings.
RESULTS
ABI measurements
ABI readings were collected for the patients enrolled in the
study. The PAD patient cohort had an average ABI of
0.64  0.21 indicating moderate disease, while the diabetic
PAD cohort had an average ABI of 0.95  0.35, which would
be misinterpreted as healthy vasculature. A statistical sig-
niﬁcance (p ¼ .05) is observed between the ABI readings
despite both cohorts being diagnosed with PAD by the
physician. This is because arterial calciﬁcations render the
arteries incompressible and falsely elevate the ABI readings.
Spatial maps of total hemoglobin change
Fig. 2 shows ﬁve representative frames during the thigh cuff
stimulus for each of the cohorts. The blood pools in the foot
as the pressure is maintained around the thigh then leaves
the foot upon release. The healthy volunteer exhibits more
blood pooling in reaction to the thigh cuff occlusion.
Hemoglobin time trace
Total hemoglobin (HbT) time traces were extracted from the
ROI within the foot. The hemoglobin time traces for each of
the three cohorts were then averaged together to obtain a
representative signal for each cohort (Fig. 3). The standard
error bars for the healthy cohort do not overlap with those
of the patient cohorts. The hemoglobin change before
release of the 60 mmHg occlusion for the healthy volun-
teers is almost double that of the patient cohorts (w10%
vs. 5%), showing the greatest discrepancy between the
cohorts. Furthermore, the hemoglobin time traces for the
PAD and the diabetic PAD cohorts are very similar, unlike
their ABI readings.
Diagnosis using the 60 mmHg occlusion peak
The 60 mmHg occlusion peaks were extracted and boxplots
were created for each cohort (Fig. 4). The boxplots show
Figure 2. This ﬁgure shows coronal cross sectional images from a healthy volunteer, a PAD patient, and a diabetic PAD patient. The ﬁve
frames shown outline the hemodynamics during the thigh cuff occlusion and release. The healthy volunteer has a greater amount of blood
pooling in the leg during the occlusion as well as a faster reaction to the application and release of the thigh cuff.
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that of the PAD and diabetic PAD patients (7.5%, 3.8%,
4.5%, respectively). The largest change within the healthy
cohort is 18.27%, while the PAD cohorts have a maximum
of less than 9% change. The range of the healthy cohort is
greater than the PAD and diabetic PAD cohorts (14.0%,
7.5%, 6.1%).
The healthy cohort had a mean of 9.84  5.44 (%), the
PAD cohort had a mean of 4.41  2.02 (%) and the diabetic
PAD cohort had a mean of 4.78  1.93 (%). Applying a one-
way ANOVA, a between group p value of .003 was obtained.
Using the Holm t-test, the healthy cohort showed a statis-
tical signiﬁcance from both PAD cohorts while the PAD and
diabetic PAD cohorts were not different from each other
(p ¼ .006, p ¼ .006, p ¼ .34).
A receiver operating characteristic (ROC) curve was
derived using the 60 mmHg peak for diagnosis (Fig. 5). This
is a good classiﬁer for PAD with an area under the ROC
curve (AUC) of 0.81. Designating D[HbT] <6.1% as afﬂicted,
a sensitivity (Se) of 0.85 and speciﬁcity (Sp) of 0.73 wereFigure 3. This ﬁgure shows the cohort average signals with their
standard error bars. The healthy cohort average’s error bars rarely
overlap with those of the PAD cohorts. Furthermore the biggest
discrepancy occurs before release of the 60 mmHg occlusion.
There is little difference between the PAD and diabetic PAD co-
horts, suggesting that VOTI is unaffected by arterial
compressibility.achieved. The positive predictive value (PPV) is 0.81 and the
accuracy of the test is 0.80. If higher speciﬁcities are
desired, the cutoff can be lowered to 5.0%, achieving a Sp
of 0.87 and Se of 0.70. The PPV is 0.88 and the accuracy of
the test is 0.77.
Severity analysis using 60 mmHg peak
To quantify VOTI’s ability to assess PAD severity, the in-
dividuals’ 60 mmHg peak values were plotted against their
respective ABI measurements (Fig. 6). For the non-diabetic
PAD individuals, a linear trend is observed between the two
parameters with an R2 ¼ 0.84 (Fig. 6A). For the diabetic
PAD cohort there is no linear relationship observed with anFigure 4. These boxplots show the distribution of D[HbT] at the
end of the 60 mmHg occlusion for each cohort. The healthy cohort
has a greater minimum, maximum, and quartiles than the affected
cohorts, signifying more pooling in the leg. The healthy cohort has
a larger range, which may be caused by lifestyle choices or
asymptotic circulatory problems. Also, note the affected cohorts
have similar distributions despite arterial calciﬁcations.
Figure 5. This ﬁgure shows a ROC curve created using the D[HbT]
before release of the 60 mmHg thigh cuff occlusion. This is a good
classiﬁer with an AUC ¼ 0.81. Designating D[HbT] <6.1% as
afﬂicted, a sensitivity of 85% and a speciﬁcity of 73% were
achieved.
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found in the PAD and diabetic PAD patients’ ABI values.
The VOTI 60 mmHg peaks were compared with the in-
dividuals’ respective foot PVR waveforms. The technicians
classiﬁed the waveforms as mild, moderate, or severely
diminished. Within the affected patient cohorts, there were
six mildly, six moderately, and eight severely diminished
waveforms. The healthy volunteers had a mean D[HbT] of
9.84  5.44%, the mildly diminished group had a mean of
5.98  1.96%, the moderately diminished group had a
mean of 4.10  1.01%, and the severely diminished group
had a mean of 3.06  0.97%. Each of the three severity
levels was signiﬁcantly different from that of the healthy
individuals (p ¼ .04, p ¼ .003, p ¼ .0007).
Angiosome analysis
Angiosome theory is a topic of great interest in vascular
surgery.24e26 Three angiosomes are captured within theFigure 6. (A) This ﬁgure shows a linear relationship between the D
[HbT] during the 60 mmHg thigh cuff occlusion and the non-
diabetic PAD patients’ ABI readings. This suggests that VOTI can
differentiate the severity of PAD similar to the ABI measurement.
(B) In diabetic PAD patients there is no relationship between ABI
measurement and D[HbT] because arterial calciﬁcation falsely el-
evates the ABI readings.mid-metatarsal, coronal cross section: the dorsalis pedis
angiosome (DPA), the medial plantar angiosome (MPA), and
the lateral plantar angiosome (LPA). Fig. 7 shows three in-
dividuals imaged using the VOTI system. In the healthy case,
the calculated signals were fairly consistent within the three
angiosomes, both in magnitude, as well as shape (Fig. 7A).
For the individuals with affected vasculature, there were
often different responses within the angiosomes (Fig. 7B),
or they had diminished signals throughout their entire foot
(Fig. 7C).DISCUSSION
VOTI is a non-invasive, non-ionizing, contrast-free imaging
modality that uses harmless red and near-infrared light to
measure changes in hemoglobin concentrations in tissue.
This technology has been applied to image PAD in the foot.
VOTI shows a statistically signiﬁcant difference between the
hemoglobin changes in healthy and affected vasculature in
the foot. There is more blood pooling resulting in high D
[HbT] in the foot during a 1 minute 60 mmHg venous oc-
clusion in healthy volunteers than in the PAD and diabetic
PAD cohorts (p ¼ .006, p ¼ .006). For large vessel disease,
the plaque buildup increases the resistance and reduces
compliance of the vessels. This leads to a reduction in the
blood pooling into the foot, resulting in lower D[HbT]. In
small vessel disease, the same effect can be caused by
arterial stenosis. This analysis was also completed for
120 mmHg occlusion, which was not as effective. The au-
thors suspect this is because of 120 mmHg causing partial
arterial occlusion in patients with lower blood pressure.
Diagnostic parameters can be extracted to form a deci-
sion boundary to diagnose PAD in the lower extremities.
The maximum hemoglobin concentration from the
60 mmHg thigh cuff occlusion was used to classify the
disease. Assessing the distribution, considerable differences
were found in the boxplots, which showed greater D[HbT]
in the healthy volunteers. A greater range was observed for
the healthy individuals, which may be caused by lifestyle
choices (e.g. diet, smoking) or other medical conditions.
Using ROC curve analysis, it was found that the 60 mmHg
D[HbT] peak was a good classiﬁer of PAD with an AUC of
0.81. Using a D[HbT] <6.1% as the decision boundary, VOTI
obtained a Se ¼ 0.85 with Sp ¼ 0.73. A lower cutoff D[HbT]
<5.0% yields a Sp ¼ 0.87 but lowers Se to 0.70. Varying the
cutoff D[HbT] enables the user to choose whether sensi-
tivity or speciﬁcity is more important in their clinical deci-
sion making.
These results indicate that a physician can effectively
diagnose patients with PAD independently of arterial cal-
ciﬁcations using VOTI, despite the ABI measurements not
being accurate. In addition, the parameters extracted from
the VOTI images correlate fairly well (R2 ¼ 0.84) with the
ABI readings for the non-diabetic PAD patients. Also,
greater D[HbT] was observed in healthy individuals than in
individuals with mildly, moderately, and severely diminished
foot PVR waveforms (p ¼ .04, p ¼ .003, p ¼ .0007). The
results showed greater D[HbT] in individuals with mildly
Figure 7. This ﬁgure shows the signals derived from the pixels with D[HbT] >10% in each angiosome. The analysis is shown for (A) healthy,
(B) PAD, and (C) diabetic PAD individuals. In the healthy individual the angiosomes behave similarly. In the PAD individual the MPA has
better perfusion than the other angiosomes of the foot. In the diabetic PAD individual, all signals are diminished suggesting a more
proximal occlusion. Angiosome analysis could help physicians plan patient treatment.
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and severely diminished waveforms. This suggests that it is
not only a decision boundary, but can identify the severity
of the disease. In addition, VOTI’s ability to non-invasively
provide localized physiological information can greatly aid
in the assessment of neuro-ischemic ulcers in diabetic PAD
patients and help with over/under-treatment of arterial
disease. Angiosome analysis using the VOTI system may aid
in treatment planning, where a physician can intervene to
improve perfusion to the most compromised areas of the
foot.27 There is currently no gold standard for assessing
angiosome perfusion, making statistical analysis difﬁcult.
Future studies involving animal models or angiographic foot
analysis in patients with distal arterial disease may help to
validate angiosome analysis using VOTI.
Unlike the traditional diagnostic modalities, VOTI pro-
vides a direct measurement of the perfusion in the entire
foot, serving as an end stage measure of the effects of the
lesions or stenosis on the foot. This technology can be used
to non-invasively diagnose and monitor patients with PAD
independent of calciﬁcation, without needing to inject
contrast into the patient’s bloodstream. This study provides
a basis for the calculations necessary in planning a largermulti-center trial. Future studies will involve greater
enrollment and control of risk factors including smoking,
age, hypertension, weight, and demographics to understand
their effects on the VOTI results.
FUNDING
This work has been funded by grants from the National
Heart, Blood, and Lung Institute (NHLBI-1R01-HL115336-
01), the Society of Vascular Surgery, and the Wallace H.
Coulter Foundation. M. Khalil has been supported by the
National Science Foundation Graduate Research Fellowship
Program and an Integrative Graduate Education and
Research Training grant (NSF-0801530).
CONFLICT OF INTEREST
None.REFERENCES
1 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA,
Fowkes FGR. Inter-society consensus for the management of
peripheral arterial disease (TASC II). Eur J Vasc Endovasc
2007;33:S5e75.
Optical Tomographic Imaging of Arterial Disease 892 Hiatt WR. Medical treatment of peripheral arterial disease and
claudication. N Engl J Med 2001;344(21):1608e21.
3 Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG,
Creager MA, Olin JW, et al. Peripheral arterial disease detec-
tion, awareness, and treatment in primary care. JAMA
2001;286(11):1317e24.
4 Kullo IJ, Bailey KR, Kardia SL, Mosley TH, Boerwinkle E,
Turner ST. Ethnic differences in peripheral arterial disease in
the NHLBI Genetic Epidemiology Network of Arteriopathy
(GENOA) study. Vasc Med 2003;8(4):237e42.
5 Diehm C, Kareem S, Lawall H. Epidemiology of peripheral
arterial disease. VASA Z Gefasskrankh 2004;33(4):183e9.
6 Garcia LA. Epidemiology and pathophysiology of lower ex-
tremity peripheral arterial disease. J Endovasc Ther 2006;13(2):
II3e9.
7 Krnic A, Vucic N, Sucic Z. Duplex scanning compared with intra-
arterial angiography in diagnosing peripheral arterial disease:
three analytical approaches. VASA Z Gefasskrankh 2006;35(2):
86e91.
8 Høyer C, Sandermann J, Petersen LJ. The toe-brachial index in
the diagnosis of peripheral arterial disease. J Vasc Surg
2013;58(1):231e8.
9 Al-Qaisi M, King DH, Kaddoura S, Hamady M. Imaging of pe-
ripheral vascular disease. Rep Med Imag 2009;2(1):25e34.
10 Casavola C, Paunescu LA, Fantini S, Gratton E. Blood ﬂow and
oxygen consumption with near-infrared spectroscopy and
venous occlusion: spatial maps and the effect of time and
pressure of inﬂation. J Biomed Opt 2000;5(3):269e76.
11 Kang Y, Lee J, Kwon K, Choi C. Application of novel dynamic
optical imaging for evaluation of peripheral tissue perfusion.
Int J Cardiol 2010;145(3):99e101.
12 Perry D, Bharara M, Armstrong DG, Mills J. Intraoperative
ﬂuorescence vascular angiography: during tibial bypass.
J Diabetes Sci Technol 2012;6(1):204e8.
13 Flexman ML, Khalil MA, Al Abdi R, Kim HK, Fong CJ,
Desperito E, et al. Digital optical tomography system for dy-
namic breast imaging. J Biomed Opt 2011;16(7):076014.
14 Pogue BW, Patterson MS, Jiang H, Paulsen KD. Initial assess-
ment of a simple system for frequency-domain diffuse optical
tomography. Phys Med Biol 1995;40(10):1709e29.
15 Pogue B, Testorf M, McBride T, Osterberg U, Paulsen K.
Instrumentation and design of a frequency-domain diffuseoptical tomography imager for breast cancer detection. Opt
Express 1997;1(13):391e403.
16 Schmitz CH, Graber HL, Luo H, Arif I, Hira J, Pei Y, et al.
Instrumentation and calibration protocol for imaging dynamic
features in dense-scattering media by optical tomography. Appl
Opt 2000;39(34):6466e86.
17 Ntziachristos V, Hielscher AH, Yodh AG, Chance B. Diffuse op-
tical tomography of highly heterogeneous media. IEEE Trans
Med Imaging 2001;20(6):470e8.
18 Hielscher AH, Bluestone AY, Abdoulaev GS, Klose AD, Lasker J,
Stewart M, et al. Near-infrared diffuse optical tomography. Dis
Markers 2002;18(5e6):313e37.
19 Khalil MA, Kim HK, Kim IK, Flexman M, Dayal R, Shrikhande G,
et al. Dynamic diffuse optical tomography imaging of periph-
eral arterial disease. Biomed Opt Express 2012;3(9):2288e98.
20 Lasker JM, Masciotti JM, Schoenecker M, Schmitz CH,
Hielscher AH. Digital-signal-processor-based dynamic imaging
system for optical tomography. Rev Sci Instrum 2007;78(8):
083706.
21 Kim HK, Flexman M, Yamashiro DJ, Kandel JJ, Hielscher AH.
PDE-constrained multispectral imaging of tissue chromophores
with the equation of radiative transfer. Biomed Opt Express
2010;1(3):812e24.
22 Lasker JM, Fong CJ, Ginat DT, Dwyer E, Hielscher AH. Dynamic
optical imaging of vascular and metabolic reactivity in rheu-
matoid joints. J Biomed Opt 2007;12(5):052001.
23 Pogue BW, Davis SC, Song X, Brooksby BA, Dehghani H,
Paulsen KD. Image analysis methods for diffuse optical to-
mography. J Biomed Opt 2006;11(3):33001.
24 McGregor AD. The angiosome e an in vivo study by ﬂuorescein
angiography. Br J Plast Surg 1992;45(3):219e21.
25 Taylor GI, Palmer JH. Angiosome theory. Br J Plast Surg
1992;45(4):327e8.
26 Suami H, Taylor GI, Pan WR. Angiosome territories of the
nerves of the lower limbs. Plast Reconstr Surg 2003;112(7):
1790e8.
27 Ferraresi R, Centola M, Ferlini M, Da Ros R, Caravaggi C,
Assaloni R, et al. Long-term outcomes after angioplasty of
isolated, below-the-knee arteries in diabetic patients with
critical limb ischaemia. Eur J Vasc Endovasc 2009;37(3):
336e42.
